![Medigen-GDT-TW-V210-sub-1080p.mp4_20201113_112625.558[870x320]](https://www.medigen.com.tw/wp-content/uploads/2020/01/Medigen-GDT-TW-V210-sub-1080p.mp4_20201113_112625.558870x320.jpg)
MEDINET (MEDINET Co., Ltd.)The Medinet Co., Ltd. was established in October 1995, and was successfully commercialized the immune cell therapy technology in 1999 and became the first biotechnology company to provide theall-round of services for medical institutions in Japan. Medinet was listed on the Tokyo Stock Exchange in 2003 (TSE Mothers # 2370).
The GDT cells produced by the Medinet have been used by more than 50 medical institutions since 2007, and the technology has been moved on to Phase II/III clinical trials.